Helena Mora-Jensen

ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells

Qiuyan Wang, Helena Mora-Jensen, Marc A. Weniger et al. · Proceedings of the National Academy of Sciences · 2009 · 340 citations · Full text

Apoptosis, Proteasome Inhibitor Bortezomib, Cell Death +20

Comparing cancer vs normal gene expression profiles identifies new disease entities and common transcriptional programs in AML patients

Nicolas Rapin, Frederik Otzen Bagger, Johan Jendholm et al. · Blood · 2013 · 161 citations

The Bruton Tyrosine Kinase (BTK) Inhibitor Acalabrutinib Demonstrates Potent On-Target Effects and Efficacy in Two Mouse Models of Chronic Lymphocytic Leukemia

Sarah E. M. Herman, Arnau Montraveta, Carsten Utoft Niemann et al. · Clinical Cancer Research · 2016 · 157 citations · Full text

Olfactomedin 4 defines a subset of human neutrophils

Stine Novrup Clemmensen, Christina T. Bohr, Sara Rørvig et al. · Journal of Leukocyte Biology · 2011 · 129 citations

Inflammation, Olfm4 Mrna, Autoimmune Disease +15

Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation

Patricia Pérez‐Galán, Helena Mora-Jensen, Marc A. Weniger et al. · Blood · 2010 · 117 citations · Full text